# Protara Therapeutics, Inc.: filings

TARA · Nasdaq · CIK 1359931 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tara.md) · [Financials](/companies/tara/financials.md) · [Filings](/companies/tara/filings.md) · [Insiders](/companies/tara/insiders.md)

## Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 318, 8-K 128, 3 45, 10-Q 36, SC 13G 20, SC 13G/A 20, CORRESP 18, SCHEDULE 13G/A 15, 144 13, 4/A 13, S-8 13, SC 13D/A 13, UPLOAD 13, 10-K 12, DEF 14A 12, EFFECT 11, 424B5 9, DEFA14A 9, S-3 9, 424B3 6, 425 5, SC 13D 5, 3/A 4, 424B7 4, ARS 4, CT ORDER 4, D 4, DRSLTR 4, SEC STAFF LETTER 4, S-4/A 3, SCHEDULE 13G 3, 10-K/A 2, 5 2, 8-K/A 2, DRS/A 2, PRE 14A 2, S-1 2, S-3/A 2, 10-Q/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, REGDEX 1, RW 1, S-1/A 1, S-1MEF 1, S-3MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 08:10 ET | [10-Q](/filings/0001213900-26-087508.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087508 |
| 2026-08-11 | 08:05 ET | [8-K](/filings/0001213900-26-087506.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-087506 |
| 2026-06-29 | 17:02 ET | [8-K](/filings/0001213900-26-073184.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-073184 |
| 2026-06-15 | 16:05 ET | [8-K](/filings/0001213900-26-068774.md) | 5.07 Shareholder vote results | 0001213900-26-068774 |
| 2026-05-13 | 08:10 ET | [10-Q](/filings/0001213900-26-055463.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055463 |
| 2026-05-13 | 08:05 ET | [8-K](/filings/0001213900-26-055462.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-055462 |
| 2026-04-28 | 16:05 ET | [DEF 14A](/filings/0001213900-26-048536.md) | Proxy statement, period 2026-06-12 | 0001213900-26-048536 |
| 2026-03-30 | 08:00 ET | [8-K](/filings/0001213900-26-035971.md) | 7.01 Regulation FD disclosure | 0001213900-26-035971 |
| 2026-03-10 | 08:11 ET | [10-K](/filings/0001213900-26-025433.md) | Annual report, period 2025-12-31 | 0001213900-26-025433 |
| 2026-03-10 | 08:06 ET | [8-K](/filings/0001213900-26-025432.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-025432 |
| 2026-02-24 | 08:52 ET | [8-K](/filings/0001213900-26-019617.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019617 |
| 2025-12-15 | 16:15 ET | [8-K](/filings/0001213900-25-121687.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-121687 |
| 2025-12-08 | 16:15 ET | [8-K](/filings/0001213900-25-119242.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-119242 |
| 2025-12-03 | 08:08 ET | [8-K](/filings/0001213900-25-117577.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-117577 |
| 2025-11-19 | 09:15 ET | [8-K](/filings/0001213900-25-112383.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112383 |
| 2025-11-10 | 08:10 ET | [10-Q](/filings/0001213900-25-107881.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107881 |
| 2025-11-10 | 08:05 ET | [8-K](/filings/0001213900-25-107873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107873 |
| 2025-08-11 | 08:11 ET | [10-Q](/filings/0001213900-25-073942.md) | Quarterly report, period 2025-06-30 | 0001213900-25-073942 |
| 2025-08-11 | 08:05 ET | [8-K](/filings/0001213900-25-073937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-073937 |
| 2025-06-12 | 16:17 ET | [8-K](/filings/0001213900-25-053844.md) | 5.07 Shareholder vote results | 0001213900-25-053844 |
| 2025-05-08 | 08:10 ET | [10-Q](/filings/0001213900-25-040811.md) | Quarterly report, period 2025-03-31 | 0001213900-25-040811 |
| 2025-05-08 | 08:05 ET | [8-K](/filings/0001213900-25-040809.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-040809 |
| 2025-04-28 | 08:35 ET | [8-K](/filings/0001213900-25-035785.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035785 |
| 2025-04-25 | 16:13 ET | [DEF 14A](/filings/0001213900-25-035568.md) | Proxy statement, period 2025-06-11 | 0001213900-25-035568 |
| 2025-03-05 | 08:16 ET | [10-K](/filings/0001213900-25-020368.md) | Annual report, period 2024-12-31 | 0001213900-25-020368 |
| 2025-03-05 | 08:07 ET | [8-K](/filings/0001213900-25-020366.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-020366 |
| 2025-01-13 | 16:34 ET | [8-K](/filings/0001213900-25-003026.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-003026 |
| 2024-12-11 | 16:19 ET | [8-K](/filings/0001213900-24-107906.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-107906 |
| 2024-12-05 | 08:45 ET | [8-K](/filings/0001213900-24-105782.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-105782 |
| 2024-11-12 | 08:10 ET | [10-Q](/filings/0001213900-24-096252.md) | Quarterly report, period 2024-09-30 | 0001213900-24-096252 |
| 2024-11-12 | 08:05 ET | [8-K](/filings/0001213900-24-096243.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-096243 |
| 2024-08-06 | 08:10 ET | [10-Q](/filings/0001213900-24-065380.md) | Quarterly report, period 2024-06-30 | 0001213900-24-065380 |
| 2024-08-06 | 08:05 ET | [8-K](/filings/0001213900-24-065378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-065378 |
| 2024-06-10 | 16:05 ET | [8-K](/filings/0001213900-24-051210.md) | 5.07 Shareholder vote results | 0001213900-24-051210 |
| 2024-05-02 | 08:10 ET | [10-Q](/filings/0001213900-24-038757.md) | Quarterly report, period 2024-03-31 | 0001213900-24-038757 |
| 2024-05-02 | 08:05 ET | [8-K](/filings/0001213900-24-038756.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-038756 |
| 2024-04-26 | 16:05 ET | [DEF 14A](/filings/0001213900-24-036627.md) | Proxy statement, period 2024-06-07 | 0001213900-24-036627 |
| 2024-04-05 | 08:14 ET | [8-K](/filings/0001213900-24-030623.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-030623 |
| 2024-03-18 | 17:17 ET | [8-K](/filings/0001213900-24-023589.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-023589 |
| 2024-03-13 | 08:10 ET | [10-K](/filings/0001213900-24-021982.md) | Annual report, period 2023-12-31 | 0001213900-24-021982 |
| 2024-03-13 | 08:05 ET | [8-K](/filings/0001213900-24-021981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-021981 |
| 2023-11-03 | 08:20 ET | [10-Q](/filings/0001213900-23-083013.md) | Quarterly report, period 2023-09-30 | 0001213900-23-083013 |
| 2023-11-03 | 08:10 ET | [8-K](/filings/0001213900-23-083011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-083011 |
| 2023-08-03 | 08:20 ET | [10-Q](/filings/0001213900-23-062782.md) | Quarterly report, period 2023-06-30 | 0001213900-23-062782 |
| 2023-08-03 | 08:12 ET | [8-K](/filings/0001213900-23-062780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-062780 |
| 2023-06-08 | 16:06 ET | [8-K](/filings/0001213900-23-047460.md) | 5.07 Shareholder vote results | 0001213900-23-047460 |
| 2023-05-04 | 08:10 ET | [10-Q](/filings/0001213900-23-036113.md) | Quarterly report, period 2023-03-31 | 0001213900-23-036113 |
| 2023-05-04 | 08:05 ET | [8-K](/filings/0001213900-23-036112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-036112 |
| 2023-05-02 | 08:05 ET | [8-K](/filings/0001213900-23-035154.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-035154 |
| 2023-04-28 | 08:10 ET | [8-K](/filings/0001213900-23-033507.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-033507 |

Page 1 of 5. [Older](/companies/tara/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.